AZD7442

AZD7442 Uses, Dosage, Side Effects, Food Interaction and all others data.

AZD7442 is a combination of SARS-CoV-2 antibodies (AZD8895 + AZD1061) currently undergoing phase I clinical trials for the prevention and treatment of COVID-19. It was developed by AstraZeneca with the goal of conferring at least 6 months of protection against COVID-19 - a significantly longer window of efficacy than that of other vaccines.

Trade Name AZD7442
Generic AZD7442
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
AZD7442
AZD7442

Innovators Monograph

You find simplified version here AZD7442


*** Taking medicines without doctor's advice can cause long-term problems.
Share